Managed Healthcare Executive

02/27/2025

How do payer contracts and reimbursement policies influence biosimilar adoption? Eric Tichy, PharmD, MBA, BCPS, FCCP, FAST, discusses decision-making process in this K-Cast episode. Watch here: https://bit.ly/4hVSBO2

02/25/2025

As an industry leader, you need to stay ahead of the curve in managed care. We’ve got the insights you need! 💡 Subscribe to our free e-newsletter and print publication to get expert trends, analysis, and updates—delivered straight to you. Don't miss out! 📩 https://bit.ly/3UZzbxB

02/21/2025

The February issue of Managed Healthcare Executive is here!

Dive into our featured story on changing the narrative about health insurance.

Get the insights you need to stay ahead in managed care. Read now: https://bit.ly/3ERLIP9
#2025

02/20/2025

Funding will be cut to $10 million, which is a nearly 90% decrease from 2024’s budget of $98 million.
https://www.managedhealthcareexecutive.com/view/cms-announces-cuts-to-aca-navigator-program

02/19/2025

Narcolepsy can greatly impact a patient’s quality of life. Learn about treatment options, challenges, and patient experience with this K-cast episode. Watch now: https://bit.ly/414tPnI

02/18/2025

Ed DeVaney has been appointed president of CVS Caremark, the pharmacy benefit management (PBM) business of CVS Health.

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.

02/18/2025

Every year, we’re inspired by healthcare leaders transforming the industry. This year’s 12 winners will be featured on the cover of our June 2025 issue!

⏰ Nominations are open until March 21 at 5 p.m. ET. Nominees must have 15 years or less in the field.

Don’t miss your chance to recognize these trailblazers! 🙌https://bit.ly/415g8ER

02/17/2025

🚨 Urgent: Exclusive Webinar Tomorrow! 🚨

Don’t miss out! Join top industry leaders and Washington D.C. healthcare experts tomorrow for an in-depth look at the early days of Trump Healthcare.

Key discussion topics include:
🔥 RFK Jr.'s nomination and its potential impact
🔥 The end of DEI and its far-reaching effects
🔥 DOGE and the latest HHS updates
🔥 The IRA's influence on healthcare policy
🔥 The future of PBM reform

This is your last chance to register before it’s too late!
Webinar is tomorrow—sign up now!
Register here: https://bit.ly/4jTAI3K

02/14/2025

This Valentine’s Day, we want to send a HUGE thank you to all the amazing people who make everything we do possible—our wonderful clients, our dedicated team, and our incredible partners. Your support, trust, and hard work inspire us every day. We’re so grateful for each of you! ♥️

02/14/2025

Progressive pulmonary fibrosis can impact a patient’s daily activities and quality of life. Experts explore the challenges that come with disease progression in this K-Cast episode. Watch the video to learn more: https://bit.ly/3Qe7Ky5

02/13/2025

Check out the February Issue! This month's cover story examines strategies for reshaping the narrative of health insurance at a time when public trust in the industry is uncertain.
https://www.managedhealthcareexecutive.com/journals/mhe-publication

02/13/2025

Those voting to support Robert F. Kennedy Jr as Secretary of HHS include Louisiana Republican Sen. Bill Cassidy. Mitch McConnell, a Republican from Kentucky, however, voted no.
https://www.managedhealthcareexecutive.com/view/senate-confirms-rfk-jr-as-hhs-secretary

02/13/2025

Anna Podolanczuk, MD, MS, describes risk factors, epidemiology, symptoms, diagnosis, and prognosis of interstitial pulmonary fibrosis and progressive pulmonary fibrosis in this Population Health Perspectives. Watch the video here: https://bit.ly/4hCwT1m

02/13/2025

The PDUFA action date for an decision for linvoseltamab to treat adult patients with relapsed/refractory multiple myeloma is July 10, 2025.
https://www.managedhealthcareexecutive.com/view/fda-sets-review-date-for-linvoseltamab-for-multiple-myeloma

02/12/2025

We spoke recently with Craig Burton, MBA, executive director of the Biosimilars Council, a trade and lobbying group for the industry.
https://www.managedhealthcareexecutive.com/view/health-of-the-biosimilars-industry-getting-rid-of-clinical-trials-pbms-as-obstacles-to-adoption-and-other-topics-q-a-with-craig-burton-mba

02/12/2025

CVS Health’s healthcare benefits segment, which includes Aetna, had medical benefit ratio of 92.5% in 2024, because of higher utilization, an unfavorable impact of Medicare Advantage star ratings payment and higher levels of care in Medicaid.
https://www.managedhealthcareexecutive.com/view/cvs-health-sees-medical-benefit-ratio-rise-in-2024

02/11/2025

"In order to realize the full potential of biosimilar competition, there are further policy changes that need to be made in order to make that reality," Craig Burton, MBA, executive director of the Biosimilars Council

We spoke recently with Craig Burton, MBA, executive director of the Biosimilars Council, a trade and lobbying group for the biosimilars industry.

02/11/2025

🚨 Exclusive Webinar Alert! 🚨

Join industry leaders and Washington D.C. healthcare experts for a deep dive into the early days of Trump Healthcare!

Topics on the agenda include:
🔥 RFK Jr.'s nomination and its impact
🔥 The end of DEI and its implications
🔥 DOGE and HHS updates
🔥 The IRA and its influence on healthcare
🔥 PBM reform prospects

Don’t miss out on the chance to stay ahead of the curve. 💡
Register Here: https://bit.ly/4jTAI3K